News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Compound Excels at Killing Persistent and Drug-Resistant Tuberculosis, The Scripps Research Institute, Howard Hughes Medical Institute, and Albert Einstein College of Medicine Study



6/18/2013 7:08:57 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

An international team led by scientists at The Scripps Research Institute (TSRI), the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.

Hey, check out all the research scientist jobs. Post your resume today!

Read at MedicalXpress
Read at ScienceDaily
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES